This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
This article was written by Follow Victor Dergunov is an independent investor and author with 20 years experience. He preaches diversification and shares investment...
The Investor Outlook series will focus on specific indicators that measure what investors are thinking and doing about the market. This article looks at...
In November of last year I believed that shares of Thermo Fisher Scientific (NYSE:TMO) were on the road to discovery, delivering on impressive results...
The broad market enthusiasm, which has been reinvigorated by inflation seemingly fading away and the Fed finally pausing the hiking cycle in June, spurred...
One of the challenges facing financial planning is that, however helpful, it has an unavoidably boring vibe. Sure, big financial companies have attempted to...